These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17431788)

  • 21. Fluoroquinolone pharmacodynamics: prospective determination of relationships between exposure and outcome.
    Drusano GL
    J Chemother; 2000 Oct; 12 Suppl 4():21-6. PubMed ID: 11131956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents].
    Huang LP; Zhuang ML; Gu CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):210-2. PubMed ID: 19292962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the effect of an antimicrobial wound dressing on biofilms.
    Percival SL; Bowler P; Woods EJ
    Wound Repair Regen; 2008; 16(1):52-7. PubMed ID: 18211579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and biochemical changes in Pseudomonas fluorescens biofilms induced by sub-inhibitory exposure to antimicrobial agents.
    Dynes JJ; Lawrence JR; Korber DR; Swerhone GD; Leppard GG; Hitchcock AP
    Can J Microbiol; 2009 Feb; 55(2):163-78. PubMed ID: 19295649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cultivation of Pseudomonas aeruginosa dissociants under specified limitation conditions].
    Fursova PV; Mil'ko ES; Levich AP
    Mikrobiologiia; 2008; 77(2):226-31. PubMed ID: 18522325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
    Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
    Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
    Prasad SV; Ballal M; Shivananda PG
    Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating different descriptors for model design of antimicrobial peptides with enhanced activity toward P. aeruginosa.
    Jenssen H; Lejon T; Hilpert K; Fjell CD; Cherkasov A; Hancock RE
    Chem Biol Drug Des; 2007 Aug; 70(2):134-42. PubMed ID: 17683374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evolution of antibiotic consumption in an intensive care burn department].
    Thabet L; Bousselmi K; Oueslati S; Memmi M; Ben Redjeb S; Messadi AA
    Tunis Med; 2007 Dec; 85(12):1035-8. PubMed ID: 19170383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003).
    Sánchez-Romero I; Cercenado E; Cuevas O; García-Escribano N; García-Martínez J; Bouza E;
    Rev Esp Quimioter; 2007 Jun; 20(2):222-9. PubMed ID: 17893760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacodynamics for intravenous antibiotics against Gram-negative bacteria in Europe between 2002 and 2006: a report from the OPTAMA program.
    Koomanachai P; Crandon JL; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2009 Apr; 33(4):348-53. PubMed ID: 19091515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial.
    Tam VH; Louie A; Fritsche TR; Deziel M; Liu W; Brown DL; Deshpande L; Leary R; Jones RN; Drusano GL
    J Infect Dis; 2007 Jun; 195(12):1818-27. PubMed ID: 17492598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
    Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S
    Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial antigen treatment in sarcoidosis--a new paradigm?
    Tercelj M; Salobir B; Rylander R
    Med Hypotheses; 2008; 70(4):831-4. PubMed ID: 17850985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts.
    Saegeman VS; Ectors NL; Lismont D; Verduyckt B; Verhaegen J
    Burns; 2008 Mar; 34(2):205-11. PubMed ID: 18037568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia.
    Maisetta G; Mangoni ML; Esin S; Pichierri G; Capria AL; Brancatisano FL; Di Luca M; Barnini S; Barra D; Campa M; Batoni G
    Peptides; 2009 Sep; 30(9):1622-6. PubMed ID: 19520127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domains in bacterial membranes and the action of antimicrobial agents.
    Epand RM; Epand RF
    Mol Biosyst; 2009 Jun; 5(6):580-7. PubMed ID: 19462015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.